5th NASH Summit 2021
Evvnt Promotion / evvnt
Archivio
29.11.2021 - 02.12.2021 Online
10:00 am - 3:30 pm
Temi della conferenza
Masterfully combining the hottest insights on NASH from 65+ strong speaker faculty, including 45+ brand new speakers from the FDA, EMA, Takeda, Eli Lilly, Gilead, Pfizer, AstraZeneca, Ionis, Novo Nordisk and more, the 5th NASH Summit is your best opportunity to unite with fellow NASH drug developers to gain critical updates on the trailblazing research you need to meaningfully reassess your therapeutic approach and optimize your pipeline strategy for the future.
Masterfully combining the hottest insights on NASH from 65+ strong speaker faculty, including 45+ brand new speakers from the FDA, EMA, Takeda, Eli Lilly, Gilead, Pfizer, AstraZeneca, Ionis, Novo Nordisk and more, the 5th NASH Summit is your best opportunity to unite with fellow NASH drug developers to gain critical updates on the trailblazing research you need to meaningfully reassess your therapeutic approach and optimize your pipeline strategy for the future.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/848618-3?pid=4832
Speakers: Christopher Jones Director of Biology Terns Pharmaceuticals, Elias Papatheodoru Chief Executive Officer Genkyotex and more
Brochure: https://go.evvnt.com/848618-3?pid=4832
Speakers: Christopher Jones Director of Biology Terns Pharmaceuticals, Elias Papatheodoru Chief Executive Officer Genkyotex and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/848618-2?pid=4832
Ms. Kaltrina Kastrati
Medicina General, Ricerca clinica
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
